MARINUS PHARMACEUTICALS, INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a549e8ab-cc87-4f5a-9c47-e62e661e9f14/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $31.0M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002479 |
| FY 2022 | $25.5M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-003305 |
| FY 2021 | $15.3M | 2021-01-01 – 2021-12-31 | evidence 0001558370-23-003305 |
| FY 2020 | $1.7M | 2020-01-01 – 2020-12-31 | evidence 0001558370-22-004279 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001558370-17-001650 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001558370-16-003873 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MARINUS PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income